prof. Riccardo Polosa, founder of the CoEHAR and one of the leading experts in the field of harm reduction strategies, will speak at the first edition of the congress "Le strade del Respiro", which will be held on Saturday 5 November in Rome.
As in the text, the experts believe that “Spanish authorities have a golden opportunity to apply new measures in the fight against the diseases caused by smoking that are giving significant results in those countries where they are already being applied”.
Among the distinguished speakers, also the expected speech by prof. Riccardo Polosa, founder of CoEHAR.
Diasmoke 2.0 is a CoEHAR research project that aims to assess health improvements and changes in cardiovascular risk factors in smokers with Type 2 Diabetes Mellitus who switch to combustion-free nicotine delivery systems
Harm Reduction strategies were the subject of a speech by prof. Polosa during the National Congress of the Italian Society of Internal Medicine. Focus of this year edition, the management of…
Smile study is a CoEHAR research project that aims to assess the impact of cigarette smoking on oral health in four different countries around the world. Italy, October 2022- It…
During the 2022 edition of GTNF, the Global Tobacco and Nicotine Forum, Prof. Riccardo Polosa, founder of the CoEHAR, was part of an intense and engaging panel on vaping and tobacco policies at the panel “Banned! Is Prohibition Back?”.
Pasquale Caponnetto, CoEHAR member, unveiled two brand new research project during the XXX Congress of the Italian Association of Psychology, Genesis and Ceasefire. Two projects concerning mental health, smoking addiction and combustion-free products
CoEHAR Director Giovanni Li Volti and the co-project leader of the Replica project Massimo Caruso have been invited to be part of the 5th Scientific Summit on Harm Reduction in Athens to deliver a presentation on the latest results obtained by the Replica project and their implication for public health.
An independent review by the Replica project team examines the impact of tobacco smoke and electronic nicotine delivery systems use on oxidative stress, the precursor of the so-called tobacco related diseases (respiratory and cardiovascular diseases, tumors). To date, the scientific evidence available constitutes a puzzle of information, which, despite experimental and procedural limitations of international studies , already shows a reduced impact of ENDS on oxidative stress compared to cigarette smoking, even if some research have concluded that they do not completely eliminate it, leaving the question still pending
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.